电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD47 (Magrolimab Biosimilar) 抗体

This Human 单克隆 anti-CD47 (Magrolimab Biosimilar) antibody specifically detects CD47 (Magrolimab Biosimilar) in ELISA 和 FACS. The antibody is reactive with 人 samples.
产品编号 ABIN7093068
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) 抗体 (ABIN7093068)

抗原

CD47 (Magrolimab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 10
  • 2
  • 1
  • 1
Human

克隆类型

  • 11
  • 3
单克隆

标记

  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD47 (Magrolimab Biosimilar) antibody is un-conjugated

应用范围

  • 13
  • 12
  • 9
  • 1
  • 1
  • 1
ELISA, Flow Cytometry (FACS)

质量等级

Research Grade
  • 原理

    Anti-CD47 (magrolimab biosimilar, IgG1) mAb

    产品特性

    Hu5F9-G4

    纯化方法

    Purified from cell culture supernatant by affinity chromatography

    亚型

    IgG1
  • 应用备注

    ELISA 1:5000-10000, Flow Cyt 1:100

    说明

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Reconstitute with deionized water

    缓冲液

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    储存条件

    -20 °C,-80 °C

    储存方法

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    有效期

    12 months
  • 抗原

    CD47 (Magrolimab Biosimilar)

    物质类

    Biosimilar

    背景

    Synonyms: CD47, MER6, IAP

    基因ID

    961

    UniProt

    Q08722
You are here: